© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Payal Kohli, MD
Articles
Atherosclerosis: TMAO and Evidence for the “Infectious” Hypothesis
June 21, 2013
The “infectious” hypothesis of atherosclerosis (including bacterial and viral etiologies) may have new support.
Statins Plus Exercise: New Study Questions the Combination
June 17, 2013
Simvastatin 40 mg once daily can attenuate increases in cardiorespiratory fitness in response to exercise training.
Bleeding Risk in AF: Tools for Clinical Assessment
June 12, 2013
HAS-BLED, HEMORRHAGES, OBRI: Risk calculators to assess potential for bleeding in AF patients before anticoagulation.
Periprocedural Dabigatran: Risk for Increased Bleeding, Thromboembolism
June 11, 2013
Periprocedural dabigatran increases the risk of bleeding and thromboembolic complications compared with warfarin during radiofrequency ablation of AF.
Stress Testing 101
May 30, 2013
Among many considerations when ordering or interpreting a stress test are the limitations and adequacy of the stress modality (exercise, vasodilator, ionotrope) as well as the imaging modality used. Here, top-line reminders for primary care practice.
When the CHADS2 Score = 1: Will Aspirin Do or Is Warfarin Indicated?
May 16, 2013
The CHA2DS2-VASc score improves risk determination by incorporating age 65 to 74 years, female sex, and history of vascular disease.
Eplerenone Reduces Atrial Fibrillation Incidence in Heart Failure Patients
May 16, 2013
Aldosterone antagonists, eg, eplerenone, decrease adverse cardiovascular outcomes in patients with HF and AF.
HIV Severity Is Associated With AF Risk
May 02, 2013
CD4+ count and viral load were complementary and were independently associated with increased incidence of AF.
Interruption of Rivaroxaban vs Warfarin for AF: A Comparison of Risk
April 09, 2013
Interruption of anticoagulation with rivaroxaban or warfarin should be bridged with an agent such as low-molecular weight heparin.
When Anticoagulation Isn’t an Option: What to Do?
April 09, 2013
Could the left atrial appendage closure device, known as the Watchman, become an alternative to oral anticoagulation for select patients? Here, more on the 2 trials that have introduced the possibility.